Information  X 
Enter a valid email address

Telefonica Emisiones (38KE)

  Print   

Tuesday 14 May, 2019

Telefonica Emisiones

Delisting Notice

RNS Number : 8680Y
Telefonica Emisiones S.A.U.
14 May 2019
 

 

TELEFÓNICA EMISIONES, S.A.U.

(the "Issuer")

NOTICE OF CANCELLATION OF LISTING

As previously notified to holders, the securities listed below which are currently admitted to the official list of the United Kingdom Financial Conduct Authority and admitted to trading on the Regulated Market of the London Stock Exchange plc (the "London Stock Exchange"), have also been admitted to trading on the regulated market (the "Main Securities Market") of the Irish Stock Exchange plc trading as Euronext Dublin ("Euronext Dublin").  

As a consequence of this, the Issuer has requested that the United Kingdom Financial Conduct Authority and the London Stock Exchange plc cancel the admission of the securities to listing and trading respectively with effect from 12 June 2019. The admission of the securities to trading on the Main Securities Market of Euronext Dublin will continue, and will not be affected by these steps. 

For further information please contact:

Telefónica Emisiones S.A.U

Distrito Telefónica Ed. Central, Planta 2,

Ronda de la Comunicación s/n,

28050 Madrid, España

 

List of Affected Securities:

 

(1)        EUR 1,000,000,000 1.495 per cent. Instruments due September 2025 (Series 60) ISIN: XS1877846110

(2)        EUR 1,000,000,000 1.447 per cent. Instruments due January 2027 (Series 59) ISIN: XS1756296965

(3)        EUR 1,250,000,000 1.715 per cent. Instruments due January 2028 (Series 58) ISIN: XS1681521081

(4)        EUR 700,000,000 2.318 per cent. Instruments due October 2028 (Series 55) ISIN: XS1550951138

(5)        EUR 1,250,000,000 1.528 per cent. Instruments due January 2025 (Series 54) ISIN: XS1550951211

(6)        EUR 150,000,000 4.00 per cent. Instruments due December 2051 (Series 53) ISIN: XS1542177545

(7)        EUR 750,000,000 1.930 per cent. Instruments due October 2031 (Series 52) ISIN: XS1505554771

(8)        EUR 1,250,000,000 0.318 per cent. Instruments due October 2020 (Series 51) ISIN: XS1505554698

(9)        EUR 1,350,000,000 1.460 per cent. Instruments due April 2026 (Series 50) ISIN: XS1394764689

(10)      EUR 1,400,000,000 0.750 per cent. Instruments due April 2022 (Series 49) ISIN: XS1394777665

(11)      EUR 1,000,000,000 1.477 per cent. Instruments due September 2021 (Series 47) ISIN: XS1290729208

(12)      EUR 67,000,000 Floating Rate Instruments due July 2022 (Series 46) ISIN: XS1262975995

(13)      EUR 800,000,000 2.932 per cent. Instruments due October 2029 (Series 44) ISIN: XS1120892507

(14)      EUR 1,250,000,000 2.242 per cent. Instruments due May 2022 (Series 43) ISIN: XS1069430368

(15)      EUR 750,000,000 2.736 per cent. Instruments due May 2019 (Series 39) ISIN: XS0934042549

(16)      EUR 1,000,000,000 3.961 per cent. Instruments due March 2021 (Series 38) ISIN: XS0907289978

(17)      EUR 1,500,000,000 3.987 per cent. Instruments due January 2023 (Series 37) ISIN: XS0874864860

(18)      EUR 1,200,000,000 4.710 per cent. Notes due January 2020 (Series 34) ISIN: XS0842214818

(19)      GBP 700,000,000 5.597 per cent. Instruments due March 2020 (Series 30) ISIN: XS0753149144

(20)      GBP 400,000,000 5.445 per cent. Instruments due October 2029 (Series 25) ISIN: XS0545440900

(21)      GBP 650,000,000 5.289 per cent. Instruments due December 2022 (Series 21) ISIN: XS0470740530

(22)      EUR 1,750,000,000 4.693 per cent. Instruments due November 2019 (Series 20) ISIN: XS0462999573

(23)      EUR 55,000,000 Floating Rate Instruments due December 2021 (Series 9) ISIN: XS0283060324

(24)      GBP 500,000,000 5.375 per cent. Instruments due September 2026 (Series 4) ISIN: XS0241945582


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCGMGMKKFVGLZM

a d v e r t i s e m e n t